chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First dose had moderate migraine headache started 18hrs after dose through third day following dose with some nausea and vomiting.; First dose had moderate migraine headache started 18hrs after dose through third day following dose with some nausea and vomiting.; First dose had moderate migraine headache started 18hrs after dose through third day following dose with some nausea and vomiting.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07May2021 14:00 (Lot number: EW0170) at the age of 52 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Gilbert's syndrome" (unspecified if ongoing); "Rosacea" (unspecified if ongoing); "Irritable bowel syndrome" (unspecified if ongoing); "Known Allergies: Sulfa drugs" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE. Past drug history included: Cephalexin, reaction(s): "Allergies". The following information was report-ed: MIGRAINE (non-serious) with onset 08May2021, outcome "unknown", NAUSEA (non-serious), VOMITING (non-serious) all with onset May2021, outcome "unknown" and all described as "First dose had moderate migraine headache started 18hrs after dose through third day following dose with some nausea and vomiting.". Therapeutic measures were taken as a result of migraine, nausea.  Additional Information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination was only omeprazole 20mg and multivitamin daily. The patient other medical history was Gilberts syndrome, Rosacea, irritable, bowel syndrome. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. First dose had moderate migraine headache started 18hrs after dose through third day following dose with some nausea and vomiting. Second Dose had severe debilitating migraine headache 12hrs after dose with severe nausea and vomiting through 72hrs following dose. Experienced severe muscle pain during 12-30hrs post dose with temp 101, which eased off with only migraine and nausea remaining through 72hrs. adverse event start date was 29May2021. Adverse event start time was 07:00 AM  No follow-up attempts are possible. No further information is expected.
Swelling, redness, itchy rash that spread from injection site to neck a week after getting vaccine.
Moderna covid19 Pediatric dose for ages <11 years is 0.25ml.  The vial is supposed to have 0.25ml and is a single use vial.  The vial had 0.5ml.  0.5ml was administered.  The child had increased pain and fatigue the 24 hours following the vaccine administration
Diarrhea; Fatigue/still on-going symptoms of fatigue; Fever; chills; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Fatigue/still on-going symptoms of fatigue), CHILLS (chills) and PYREXIA (Fever) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939909) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (BABY ASPIRIN), PRENATAL VITAMINS [ASCORBIC ACID; BETACAROTENE; CALCIUM SULFATE; COLECALCIFEROL; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; NICOTINAMIDE; PYRIDOXINE HYDROCHLORIDE; RETINOL ACETATE; RIBOFLAVIN; THIAMINE MONONITRATE; TOCOPHERYL ACETATE; ZINC OXIDE] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 20-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, the patient experienced CHILLS (chills). On 21-Nov-2021, the patient experienced PYREXIA (Fever). On 22-Nov-2021, the patient experienced DIARRHOEA (Diarrhea) and FATIGUE (Fatigue/still on-going symptoms of fatigue). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at a dose of 500 mg. At the time of the report, DIARRHOEA (Diarrhea) and CHILLS (chills) outcome was unknown, FATIGUE (Fatigue/still on-going symptoms of fatigue) had not resolved and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Nov-2021, Body temperature: 104 (High) 104 °F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  It was reported that patient took 1 tablet Tylenol 500 mg Extra Strength on 20-Nov-2021, maybe 3-4 tablets and Tylenol 500 mg Extra Strength on 21-Nov-2021.
About 11 hrs s/p injection, experienced dizzyness and nausea. Approx 2 hrs longer (s/p 13hrs), severe chills and body aches. S/p 15hrs fever 103.2, persisted for approx 24hrs but managed with NSAID. Nausea and fatigue for approx 3-4 days following injection.
Terrible arm pain all the way down to finger tips (started 9 hours after shot) Body aches, chills (started 11 hours after shot) Nausea, chills, body aches, headache, fever  severe (16 hours after shot) Fever and body aches continued (14 more hours)   Went to bed for the night.  Fever gone and felt better by next morning. Received shot on Wednesday after didn't feel better until Friday morning.
Information has been received from a registered pharmacist (R.PH) concerning a female who on an unknown date was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (lot number not reported). There was no concomitant medication. After receiving the first dose of GARDASIL, the patient went to the emergency room for a rash. Patient was reported to have been diagnosed with thrombocytopenia and possible lupus. It was unknown how soon after receiving the vaccine patient developed rash or if it was related at all to the vaccine. On an unknown date therapy with GARDASIL was discontinued. At the time of reporting, the outcomes of thrombocytopenia and possible lupus were unknown. The patient visited office to seek medical attention. Upon internal review, possible lupus was determined to be an other important medical event. Additional information has been requested.
This case was reported by a other health professional via call center representative and described the occurrence of adverse reaction in a patient who received RABAVERT. On an unknown date, the patient received RABAVERT at an unknown dose. On an unknown date, an unknown time after receiving RABAVERT, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to RABAVERT. Additional details were provided as follows: The patient's age at vaccine administration was not reported. The reporter stated that, the patient experienced some side effects after RABAVERT vaccination.
Burning, stinging, sharp pain in anterior upper arm at and distal to the injection site and proximal to the elbow beginning several days after the injection. This is now accompanied by an area of numbness in the same area. The pain symptoms are aggravated by extension of the arm. These symptoms have persisted for the past week or so. I don?t know if they will be permanent.  I believe this was caused by injection into a peripheral nerve by injecting too distally into the deltoid.  My suggestion is to review proper injection techniques (e.g. location) to all who are giving injections.
Short of breath; Cough; Fatigue; Fever 103.8; Body hurt; A spontaneous report was received from a healthcare professional for a 40-year-old, female patient who received Moderna's COVID-19 vaccine and experienced fever of 103.8, body pain, fatigue, cough and shortness of breath.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch#:037K20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.     On 28 Dec 2020, the patient awoke with a fever of 103.8, body pain, and fatigue.   On 29 Dec 2020 she developed a cough and shortness of breath. She states all symptoms are still ongoing. Treatment for the event included acetaminophen and guaifenesin.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome of the event(s), fever of 103.8, body pain, fatigue, cough and shortness of breath, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Myalgia, fatigue and pyrexia are listed events in CCDS.
pt recv vax 28JUN94 & 2wks later JUL94 pt began rolling eyes from side to side;4wks later began throwing head as far back as could & rotating it from lt to rt w/eye movement;devel stiffness & extreme discomfort @ back of neck;fatigue
small bruise; This case was reported by a other health professional via sales rep and described the occurrence of contusion in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced contusion. On an unknown date, the outcome of the contusion was unknown.   It was unknown if the reporter considered the contusion to be related to Bexsero.  Additional information received were as follows: This case was reported by the Medical assistant (MA). The age at vaccination was not reported. The patient had a small bruise. For tolerance to 2nd dose refer linked case US2019AMR150929.
This spontaneous report was received from a Medical Assistant via company representative concerning a 14 year old female patient. Information on the patient's concomitant medications, pertinent medical history and drug reactions or allergies was unknown. In approximately December 2017 (reported as "8 months ago"), the patient was vaccinated with the first dose of GARDASIL 9, intramuscular for prophylaxis (dosing details, lot# and expiry date not reported). On an unknown date, the patient experienced an unspecified systemic adverse reaction (adverse event). It was reported that the patient had made appointments to see an unspecified number of unspecified physicians at an unspecified facility for diagnosis and treatment. It was unknown if the patient had received treatment for the event. No product quality complaint (PQC) was involved. Outcome of the event was unknown. The reporter's causality assessment was not provided.
On 13-APR-2023 at 10:00 AM had drawn up monovalent primary series of Moderna, on 14-APR-2023 morning at 10:58 was administered and vaccine held in syringe in refrigerator overnight.; No adverse event; Thursday 13-APR-2023 at 10:00 AM had drawn up/ Friday 14-APR-2023 morning at 10:58 was administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Thursday 13-APR-2023 at 10:00 AM had drawn up/ Friday 14-APR-2023 morning at 10:58 was administered), PRODUCT STORAGE ERROR (On 13-APR-2023 at 10:00 AM had drawn up monovalent primary series of Moderna, on 14-APR-2023 morning at 10:58 was administered and vaccine held in syringe in refrigerator overnight.) and NO ADVERSE EVENT (No adverse event) in a 6-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1415B) for COVID-19 prophylaxis.     It was reported that patient received any other vaccines in the 4 weeks prior to COVID-19.     On 14-Apr-2023 at 10:58 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2023 at 10:58 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Thursday 13-APR-2023 at 10:00 AM had drawn up/ Friday 14-APR-2023 morning at 10:58 was administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 13-APR-2023 at 10:00 AM had drawn up monovalent primary series of Moderna, on 14-APR-2023 morning at 10:58 was administered and vaccine held in syringe in refrigerator overnight.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Thursday 13-APR-2023 at 10:00 AM had drawn up/ Friday 14-APR-2023 morning at 10:58 was administered), PRODUCT STORAGE ERROR (On 13-APR-2023 at 10:00 AM had drawn up monovalent primary series of Moderna, on 14-APR-2023 morning at 10:58 was administered and vaccine held in syringe in refrigerator overnight.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Thursday 13-APR-2023 at 10:00 AM had drawn up/ Friday 14-APR-2023 morning at 10:58 was administered) and PRODUCT STORAGE ERROR (On 13-APR-2023 at 10:00 AM had drawn up monovalent primary series of Moderna, on 14-APR-2023 morning at 10:58 was administered and vaccine held in syringe in refrigerator overnight.).    No concomitant medications was reported. No symptoms was reported. It was reported that o the same day when vaccine was administered Rotovirus, Prednar vaccine, Flu vaccine, Vaccelus vaccine as routine vaccines was given to individuals age group. No additional dose medications or reatmet drug details was reported.
Pt recv vax on 4/25/97; on 12/10/97 pt exp grape-size bump on right thigh-moveable mass; dx=pseudorheumatoid nodule, rheumatic fever, connective tissue disease, necrobiosis lipoidica, infection-cat scratch disease
4 hours after receiving vaccines, got chills, HA, burning eyes, body aches, and severe right arm pain, red area on right arm and night sweats.
PATIENT EXPERIENCED RESPIRATORY ARREST REQUIRING BIPAP AND ADMISSION TO ICU AT LOCAL HOSPITAL ONE DAY FOLLOWING VACCINE ADMINISTRATION. PATIENT LOST PULSE UPON ARRIVAL TO HOSPITAL AND REQUIRED ALGORITHM TO BE INITIATED WITH INTUBATION.
pt recv vax & 5min later lost all color w/drowsy;laid pt flat, wanted to go to sleep, drowsy;pt took a nap which is unusual for pt;
Injection sight sore.-day of shot- still to this day Arm became painfull to lift and move several hours after- still to this day Deep consistent pain next day- still to this day Pain radiates down elbow and arm- still to this day Arm pops at top of arm - still to this day
Information has been received from a physician concerning a patient who was vaccinated with a dose of Zostavax (Oka/Merck). Subsequently the patient experienced a chicken pox rash after getting the vaccine. Unspecified medical attention was sought. The outcome was not reported. No product quality complaint was involved. Additional information has been requested.
welts on her legs and swelling in her hands; welts on her legs and swelling in her hands; This spontaneous report was received from a consumer regarding to herself;  a 66 year old female patient. . Information regarding the patient's  concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.      On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) for prophylaxis (strength, dose, frequency, route of administration, lot number and expiration date were not reported).         On an unknown date the patient experienced welts on her legs (urticaria) and swelling in her hands (peripheral swelling).      The outcome of urticaria and peripheral swelling was reported as recovered.     The reporter considered urticaria and peripheral swelling to be related to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II).
Symptoms started to occur roughly an hour and a half after the injection. Symptoms included tingling of pins and needles throughout my body. A weird overwhelming feeling that something was wrong with my body but I did not know what and that my body was going to shut down. I would go through phases where my body would get overwhelmed flushed and hot and I would be confused or dazed in that moment until it passed. I started to have vision problems in my right eye with it going blurry and pain behind my left eye almost as if it was swollen. It felt like there was something in the back of my thought and I had to cough to get it out and it felt like that my bottom lip was swollen. When I got to the ER because I did not know what was going on when waiting in the waiting room my symptoms worsened. In the ER lobby I started having issues with my speech with not being able to say what I wanted to say and repeating the somethings over and over again. The tingling starting going into my throat, neck, and head area and I started getting sharp pain in my head. When everything started to intensify the knot in my throat got worse and I started coughing more. Before I knew it I was unable to swallow, I was unable to breath, it felt like my throat was closing shut and I had to tell medical staff due to still being in the ER lobbing and not having any type of medication. I felt like I was going to pass out and was seeing flying dots due to having a hard time breathing, it felt like I was going to choke on my tongue and my throat was completely impeded.   After being taken back in the ER they provided me with the following medications. diphenhydraAMINE 50 MG/ML, dexAMETHasone sodium phos, famotidine 20 mg/2 mL ink, EPINEPHrine 1 mg/mL. 1 mL inj. And was monitored until my vitals were stable to go home.
Initial report received from Health care professional on 30 July 2014. A '40-year-old' female patient, whose concomitant medication were not reported, had received a dose of TD (Lot number, Expiration date, and site of vaccination were not reported) on an unspecified date and patient had experienced fever, malaise and generalized body aches. It was advised that not to take this TD vaccine again. The laboratory details and corrective treatment were not reported. The outcome of the event was resolved on an unspecified date. List of documents held by sender: none.
She is curious because she was just diagnosed with an immune disease; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) (at 61-year-old) at second dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at first dose, single for COVID-19 immunisation. The patient was curious because she was just diagnosed with an immune disease recently. She asked if side effects can start 4 weeks after receiving the second dose of the vaccine. The outcome of the event was unknown.  Information on lot/batch number has been requested.
7/30/21: Patient arrived at the ER due to generalized weakness and lethargy after being found on the floor during a wellness check. Patient tested positive for COVID on 7/30/2021.  Diagnosed with: COVID-19 pneumonia Please note: Patient received First dose of Pfizer COVID-19 vaccine on 1/29/2021, followed by the second dose on 2/26/2021 (confirmed through electronic symptoms)  8/12/21: patient still admitted at the time of this report submission.
Had 2nd HPV vaccine 2/10/09;  starting 3/24 begin with itchy rash over feet which spread to much of torso.  By 4/09 developed muscle weakness & muscle twitches but no muscle pain.  Also developed severe sweating.  Had elevated ANA but also has celiac sprue & Type 1 DM.  Has been seen by Rheum + Derm.  No diagnoses made others than? chronic autoimmune urticaria.
reaction question; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (reaction question) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction question). At the time of the report, VACCINATION COMPLICATION (reaction question) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported.
I had my first dose 12/28/2020 and I got sick on 12/31/2020 and I tested positive for Covid 01/01/2021 I went to Urgent care and was almost hospital. My first rapid came back negative but sent a PCR and that came back Positive. Urgent care sent me to ER. They prescribed Zinc and Albuterol  that is all. A few days later I did do a telehealth visit with Dr for a follow up on 01/06/2021 and had me continue Zinc and Albuterol and I didn't need albuterol too much and she added Vitamin C an D . Tylenol for fever
Swelling 4-5cm diameter, erythema & pain peaked @ 48hrs; Gone in 5 days;
Patient was given the vaccine and sat in a chair to wait and monitor for any adverse reactions. After about 5 minutes she seized and blacked out. She came to pretty quickly, within a minute, and was responding to verbal cues. After becoming more responsive she began to feel nauseous and vomited. We gave her some water to drink. When paramedics arrived she was no longer vomiting and was back to normal responsiveness but still pale. They stayed with her for about 15 to 20 minutes and determined that she was okay to go home.
vesicular rash rt extremity, neck, abd, lt arm, rt breast;afeb;
Severe dizziness 1 hour after immunization, cleared after 1/2 hour.  Starting day after vaccination, awoke with dizziness, nausea, chills.  Diarrhea later in day.  Starting 3 days after vaccine, painful and swollen and hard supraclavicular, Left axilla, cervical lymph nodes.  Dizziness and nausea persist.  Fatigue requiring 12 hours sleep.  Paresthesias (tingling, "pins and needles"), both lower extremities, from toe to knee, unremitting, worst on day 2 after vaccination.